CUV 1.61% $14.68 clinuvel pharmaceuticals limited

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-14

  1. 7,705 Posts.
    lightbulb Created with Sketch. 2797

    CLINUVEL recorded cash receipts of $11,442,000 and net operating cash flows of $4,087,000 for the
    March quarter of 2022. The results in cash receipts exceed the next highest comparative result by 75%


    Lies, damned lies and statistics.

    Compared with the average quarter for 2021 the results for Q122

    - cash receipts down 21%

    - Expenditures up

    - Cash flow down 45%






    -

 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.